<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35569927</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1349-7235</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>10</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Internal medicine (Tokyo, Japan)</Title><ISOAbbreviation>Intern Med</ISOAbbreviation></Journal><ArticleTitle>Effects of Long-term Hybrid Assistive Limb Use on Gait in Patients with Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>1479</StartPage><EndPage>1484</EndPage><MedlinePgn>1479-1484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2169/internalmedicine.8030-21</ELocationID><Abstract><AbstractText>Objective To assess the long-term effects of hybrid assistive limb (HAL) treatment on gait in patients with amyotrophic lateral sclerosis (ALS). Methods Three courses of treatment with HAL were administered to three women with ALS. Each course had a four- to five-week duration, during which the treatment was performed nine times, with a rest period of at least two months between each course. Gait ability (2-minutes-walk and 10-m-walk tests), ALS Functional Rating Scale-Revised, and respiratory function tests were performed before and after each treatment course. Patients Patients diagnosed with ALS, according to the updated Awaji criteria, by board-certified neurologists in the Department of Neurology and Department of Rehabilitation Medicine, Toho University Omori Faculty of Medicine between January and December 2019 were recruited. Results The average time from the start to the end of the 3 courses was 319.7&#xb1;33.7 days. A multiple regression analysis was performed for the 2-minutes-walk and 10-m-walk tests, using the baseline value, each participant's ID, and time point as covariates. Changes after each course were considered outcomes. Following the 3 treatment courses, the 2-minutes walk distance improved by 16.61 m (95% confidence interval, -9.33-42.54) compared with the baseline value, but this improvement was not statistically significant (p=0.21). However, cadence significantly improved by 1.30 steps (95% confidence interval, 0.17-2.42; p=0.02). Conclusion Long-term, repetitive HAL treatments may help patients with ALS maintain their gait.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morioka</LastName><ForeName>Harumi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murata</LastName><ForeName>Kiyoko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugisawa</LastName><ForeName>Tatsuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibukawa</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebina</LastName><ForeName>Junya</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawada</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanashiro</LastName><ForeName>Sayori</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagasawa</LastName><ForeName>Junpei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanagihashi</LastName><ForeName>Masaru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirayama</LastName><ForeName>Takehisa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchi</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawabe</LastName><ForeName>Kiyokazu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebihara</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murakami</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Statistics, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Niigata National Hospital, National Hospital Organization, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kano</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Intern Med</MedlineTA><NlmUniqueID>9204241</NlmUniqueID><ISSNLinking>0918-2918</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005684" MajorTopicYN="N">Gait</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070857" MajorTopicYN="N">Walk Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016138" MajorTopicYN="N">Walking</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cyborg robot</Keyword><Keyword MajorTopicYN="N">gait ability</Keyword><Keyword MajorTopicYN="N">hybrid assistive limb</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword></KeywordList><CoiStatement>
<b>The authors state that they have no Conflict of Interest (COI).</b>
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>15</Day><Hour>21</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35569927</ArticleId><ArticleId IdType="pmc">PMC9177366</ArticleId><ArticleId IdType="doi">10.2169/internalmedicine.8030-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Writing G, Edaravone ALSSG. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16: 505-512, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347: 1425-1431, 1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras I, Yuruker S, Aytan N, et al. . Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res 1313: 192-201, 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892864</ArticleId><ArticleId IdType="pubmed">19968977</ArticleId></ArticleIdList></Reference><Reference><Citation>Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 191: 133-137, 2001.</Citation><ArticleIdList><ArticleId IdType="pubmed">11677004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamoto H, Kamibayashi K, Nakata Y, et al. . Pilot study of locomotion improvement using hybrid assistive limb in chronic stroke patients. BMC Neurol 13: 141, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3851710</ArticleId><ArticleId IdType="pubmed">24099524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueba T, Hamada O, Ogata T, Inoue T, Shiota E, Sankai Y. Feasibility and safety of acute phase rehabilitation after stroke using the hybrid assistive limb robot suit. Neurol Med Chir 53: 287-290, 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">23708218</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson A, Vreede KS, Haglund V, Kawamoto H, Sankai Y, Borg J. Gait training early after stroke with a new exoskeleton--the hybrid assistive limb: a study of safety and feasibility. J Neuroeng Rehabil 11: 92, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4065313</ArticleId><ArticleId IdType="pubmed">24890413</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Tanaka N, Inuta T, Saitou H, Yanagi H. Locomotion improvement using a hybrid assistive limb in recovery phase stroke patients: a randomized controlled pilot study. Arch Phys Med Rehabil 95: 2006-2012, 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">25010538</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Goto R, Tanaka N, Matsumura A, Yanagi H. Effects of gait training using the hybrid assistive limb in recovery-phase stroke patients: a 2-month follow-up, randomized, controlled study. NeuroRehabilitation 40: 363-367, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28222558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda H, Samura K, Hamada O, et al. . Effectiveness of acute phase hybrid assistive limb rehabilitation in stroke patients classified by paralysis severity. Neurol Med Chir 55: 487-492, 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628200</ArticleId><ArticleId IdType="pubmed">26041627</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota C, Yamamoto Y, Kamada M, et al. . Acute stroke rehabilitation for gait training with cyborg type robot hybrid assistive limb: a pilot study. J Neurol Sci 404: 11-15, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31323516</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall A, Borg J, Palmcrantz S. Clinical application of the hybrid assistive limb (HAL) for gait training - a systematic review. Front Syst Neurosci 9: 48, 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4373251</ArticleId><ArticleId IdType="pubmed">25859191</ArticleId></ArticleIdList></Reference><Reference><Citation>Sczesny-Kaiser M, Hoffken O, Aach M, et al. . HAL exoskeleton training improves walking parameters and normalizes cortical excitability in primary somatosensory cortex in spinal cord injury patients. J Neuroeng Rehabil 12: 68, 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4545929</ArticleId><ArticleId IdType="pubmed">26289818</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen O, Grasmuecke D, Meindl RC, et al. . Hybrid assistive limb exoskeleton HAL in the rehabilitation of chronic spinal cord injury: proof of concept; the results in 21 patients. World Neurosurg 110: e73-e78, 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">29081392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa S, Mutsuzaki H, Mataki Y, et al. . Newly developed hybrid assistive limb for pediatric patients with cerebral palsy: a case report. J Phys Ther Sci 31: 702-707, 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6698473</ArticleId><ArticleId IdType="pubmed">31528013</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Mutsuzaki H, Mataki Y, et al. . Safety and immediate effect of gait training using a hybrid assistive limb in patients with cerebral palsy. J Phys Ther Sci 30: 1009-1013, 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6110229</ArticleId><ArticleId IdType="pubmed">30154591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizui D, Nakai Y, Okada H, Kanai M, Yamaguchi K. A case of spinal and bulbar muscular atrophy with improved walking ability following gait training using the hybrid assistive limb (HAL). Rinsho Shinkeigaku 59: 157-159, 2019. (in Japanese, Abstract in English).</Citation><ArticleIdList><ArticleId IdType="pubmed">30814446</ArticleId></ArticleIdList></Reference><Reference><Citation>Saita K, Morishita T, Hyakutake K, et al. . Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia. J Neurol Sci 373: 182-187, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28131185</ArticleId></ArticleIdList></Reference><Reference><Citation>Sczesny-Kaiser M, Kowalewski R, Schildhauer TA, et al. . Treadmill training with HAL exoskeleton - a novel approach for symptomatic therapy in patients with limb-girdle muscular dystrophy-preliminary study. Front Neurosci 11: 449, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5550721</ArticleId><ArticleId IdType="pubmed">28848377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsunoda S, Ito H, Abe M, Horikoshi K, Fukutake S. Three cases of amyotrophic lateral sclerosis in which long-term intermittent gait training was performed using a hybrid assistive limb (HAL). Neurol Therap 38: 53-56, 2021.</Citation></Reference><Reference><Citation>Nakajima T, Sankai Y, Takata S, et al. . Cybernic treatment with wearable cyborg hybrid assistive limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001). Orphanet J Rare Dis 16: 304, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261928</ArticleId><ArticleId IdType="pubmed">34233722</ArticleId></ArticleIdList></Reference><Reference><Citation>Horikoshi K, Ito H, Fukutake S, et al. . A case of amyotrophic lateral sclerosis in which long-term gait training was performed using a hybrid assistive limb. Neurol Therap 36: 601-605, 2019.</Citation></Reference><Reference><Citation>Geevasinga N, Loy CT, Menon P, et al. . Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data. Clin Neurophysiol 127: 2684-2691, 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27212114</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bernhardi R, Bernhardi LE, Eugenin J. What is neural plasticity? Adv Exp Med Biol 1015: 1-15, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">29080018</ArticleId></ArticleIdList></Reference><Reference><Citation>Power JD, Schlaggar BL. Neural plasticity across the lifespan. Wiley Interdiscip Rev Dev Biol 6: e216, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5193480</ArticleId><ArticleId IdType="pubmed">27911497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankai Y, Hasegawa Y. Cybernics: fusion of human, machine and information systems. Springer, Tokyo, 2014.</Citation></Reference><Reference><Citation>Edelman GM. Neural Darwinism. The Theory of Neuronal Group Selection. Basic Books, New York, 1987.</Citation></Reference><Reference><Citation>Hebb D. The Organization of Behavior: A Neuropsychological Theory. Wiley, New York, 1949.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>